Neuronetics Inc has a consensus price target of $6.75, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, JMP Securities, and Canaccord Genuity on March 6, 2024, May 10, 2023, and March 8, 2023. With an average price target of $9 between Piper Sandler, JMP Securities, and Canaccord Genuity, there's an implied 136.84% upside for Neuronetics Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/06/2024 | STIM | Buy Now | Neuronetics | $3.80 | 110.53% | Piper Sandler | Adam Maeder | $7 → $8 | Reiterates | Overweight → Overweight | Get Alert |
05/10/2023 | STIM | Buy Now | Neuronetics | $3.80 | 215.79% | JMP Securities | David Turkaly | → $12 | Reiterates | → Market Outperform | Get Alert |
03/08/2023 | STIM | Buy Now | Neuronetics | $3.80 | 84.21% | Canaccord Genuity | William Plovanic | $9 → $7 | Maintains | Buy | Get Alert |
03/08/2023 | STIM | Buy Now | Neuronetics | $3.80 | 215.79% | JMP Securities | David Turkaly | → $12 | Reiterates | → Market Outperform | Get Alert |
10/14/2021 | STIM | Buy Now | Neuronetics | $3.80 | 215.79% | JMP Securities | David Turkaly | — | Maintains | Market Outperform | Get Alert |
10/13/2021 | STIM | Buy Now | Neuronetics | $3.80 | — | BTIG | Marie Thibault | — | Downgrade | Buy → Neutral | Get Alert |
The latest price target for Neuronetics (NASDAQ: STIM) was reported by Piper Sandler on March 6, 2024. The analyst firm set a price target for $8.00 expecting STIM to rise to within 12 months (a possible 110.53% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Neuronetics (NASDAQ: STIM) was provided by Piper Sandler, and Neuronetics reiterated their overweight rating.
There is no last upgrade for Neuronetics.
The last downgrade for Neuronetics Inc happened on October 13, 2021 when BTIG changed their price target from N/A to N/A for Neuronetics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Neuronetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Neuronetics was filed on March 6, 2024 so you should expect the next rating to be made available sometime around March 6, 2025.
While ratings are subjective and will change, the latest Neuronetics (STIM) rating was a reiterated with a price target of $7.00 to $8.00. The current price Neuronetics (STIM) is trading at is $3.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.